Nielsen H, Kowalski A, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3454120 A1, 2015-07-24.
发明人何建平,高志强,刘建华. "Method for the Synthesis of 4-(4-(4-Chlorophenyl)-2-(propan-2-ylidenehydrazono)thiazol-3(2H)-yl)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one" [P]. 中国发明专利, 专利号 CN 115251607 B, 授权公告日 2016-07-24.
发明人唐晓军,张德明,徐明华. "A Process for Preparing High-Purity 4-(4-(4-Chlorophenyl)-2-(propan-2-ylidenehydrazono)thiazol-3(2H)-yl)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one" [P]. 中国发明专利, 专利号 CN 114892198 B, 授权公告日 2020-08-03.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2020, 999, 8723-8739.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2014, 221, (9), 9674-9695.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 4-(4-(4-Chlorophenyl)-2-(propan-2-ylidenehydrazono)thiazol-3(2H)-yl)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one Using HRMS and NMR". Sci. Total Environ., 2024, 2441, (1), 3666-3683.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2017, 691, (5), 5016-5022.